USD 16.41
(0.0%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 | 67.62 Billion JPY | -4.96% |
2023 | 68.86 Billion JPY | 11.1% |
2022 | 61.98 Billion JPY | 3.39% |
2021 | 59.95 Billion JPY | 12.13% |
2020 | 53.46 Billion JPY | 22.79% |
2019 | 43.54 Billion JPY | 3.44% |
2018 | 42.09 Billion JPY | 16.82% |
2017 | 36.03 Billion JPY | 24.07% |
2016 | 29.04 Billion JPY | 37.84% |
2015 | 21.07 Billion JPY | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 FY | - JPY | -1.79% |
2024 Q1 | 13.34 Billion JPY | -34.36% |
2024 Q4 | 18.37 Billion JPY | 150.91% |
2024 Q3 | 12.48 Billion JPY | -68.73% |
2024 Q2 | 23.41 Billion JPY | 75.41% |
2023 Q2 | 21.83 Billion JPY | 67.64% |
2023 Q1 | 13.02 Billion JPY | -29.47% |
2023 FY | - JPY | 11.1% |
2023 Q4 | 20.33 Billion JPY | 51.67% |
2023 Q3 | 13.4 Billion JPY | -38.59% |
2022 Q2 | 20.02 Billion JPY | 72.35% |
2022 Q1 | 11.61 Billion JPY | -18.45% |
2022 FY | - JPY | 3.39% |
2022 Q4 | 18.46 Billion JPY | 56.44% |
2022 Q3 | 11.8 Billion JPY | -41.05% |
2021 Q1 | 14.44 Billion JPY | -15.73% |
2021 Q2 | 20 Billion JPY | 38.54% |
2021 Q4 | 14.24 Billion JPY | 36.93% |
2021 FY | - JPY | 12.13% |
2021 Q3 | 10.4 Billion JPY | -48.0% |
2020 FY | - JPY | 22.79% |
2020 Q2 | 14.11 Billion JPY | 20.04% |
2020 Q4 | 17.13 Billion JPY | 74.62% |
2020 Q1 | 11.76 Billion JPY | -9.45% |
2020 Q3 | 9.81 Billion JPY | -30.48% |
2019 Q4 | 12.98 Billion JPY | 63.02% |
2019 FY | - JPY | 3.44% |
2019 Q3 | 7.96 Billion JPY | -35.87% |
2019 Q2 | 12.42 Billion JPY | 30.62% |
2019 Q1 | 9.51 Billion JPY | -24.0% |
2018 Q2 | 11.19 Billion JPY | 19.76% |
2018 FY | - JPY | 16.82% |
2018 Q4 | 12.51 Billion JPY | 53.47% |
2018 Q1 | 9.34 Billion JPY | -11.78% |
2018 Q3 | 8.15 Billion JPY | -27.17% |
2017 Q2 | 10.04 Billion JPY | 43.86% |
2017 FY | - JPY | 24.07% |
2017 Q4 | 10.59 Billion JPY | 43.28% |
2017 Q3 | 7.39 Billion JPY | -26.37% |
2017 Q1 | 6.98 Billion JPY | -24.4% |
2016 Q1 | 5.13 Billion JPY | 0.0% |
2016 FY | - JPY | 37.84% |
2016 Q4 | 9.23 Billion JPY | 43.26% |
2016 Q3 | 6.44 Billion JPY | -6.14% |
2016 Q2 | 6.86 Billion JPY | 33.69% |
2015 FY | - JPY | 0.0% |
2015 Q2 | 5.55 Billion JPY | 14.9% |
2015 Q3 | 3.96 Billion JPY | -28.65% |
2015 Q1 | 4.83 Billion JPY | -15.13% |
2014 Q4 | 5.69 Billion JPY | 17.08% |
2014 Q3 | 4.86 Billion JPY | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Alternative Energy Partners, Inc. | -251.11 USD | 26930428995.703% |
Allstar Health Brands, Inc. | -241.78 Thousand USD | 27968932.071% |
Beijing Tong Ren Tang Chinese Medicine Company Limited | 89.4 Million USD | -75542.293% |
Café Serendipity Holdings, Inc. | -1.41 Million USD | 4778252.415% |
Decision Diagnostics Corp. | - USD | -Infinity% |
Health Advance Inc. | -47.95 Thousand USD | 141008899.366% |
HealthWarehouse.com, Inc. | -1.27 Million USD | 5302744.775% |
LIGAND PHARMACEUTICAL INC | 47.23 Million USD | -143076.236% |
MedGen, Inc. | -15.37 USD | 439980481557.385% |
Omni Health, Inc. | 1.28 Million USD | -5251927.418% |
Oxford Investments Holdings Inc. | -343.96 Thousand USD | 19660473.409% |
Pineapple, Inc. | -1.47 Million USD | 4583981.818% |
ScripsAmerica, Inc. | -3.95 Million USD | 1710190.965% |